Tevra Brands LLC v. Bayer HealthCare LLC

Good Law
United States District Court, Northern District of CaliforniaMarch 16, 20205:19-cv-04312California1,106 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 TEVRA BRANDS LLC, Case No. 19-cv-04312-BLF

Plaintiff,

ORDER GRANTING PLAINTIFF’S

v. MOTION FOR LEAVE TO AMEND

AND TERMINATING BAYER

BAYER HEALTHCARE LLC, et al., HEALTHCARE LLC’S MOTION TO

DISMISS THE COMPLAINT

Defendants. [ECF 25, 79] 12 On July 26, 2019, Plaintiff Tevra Brands LLC (“Tevra”) sued Defendants Bayer HealthCare LLC (“Bayer HealthCare”), Bayer Animal Health GmbH (“Bayer Animal”), and Bayer AG, alleging various violations of the Clayton Antitrust Act and the Sherman Antitrust Act. ECF 1. The suit concerns topical flea and tick treatments containing the active ingredient Imidacloprid. Id. ¶¶ 1,15. The Complaint claimed, inter alia, that Defendants have (1) forced retailers and distributors to agree not to carry generic Imidacloprid topicals in competition with Defendants’ name brand products, id. ¶ 3, and (2) illegally tied the purchase of their topical treatments with…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.